--2025/Q1-- / 11.365M--
--2024/Q4-- / 7.715M--
Nov 7, 20242024/Q39.111M / 7.856M--
Aug 8, 20242024/Q26.957M / 19.162M--
May 9, 20242024/Q128.935M / 9.065M--
US Stock MarketDetailed Quotes
NTLA Intellia Therapeutics
- 16.730
- +0.730+4.56%
Close Nov 8 16:00 ET
- 16.730
- 0.0000.00%
Post 20:01 ET
1.70BMarket Cap-3069P/E (TTM)
16.995High15.610Low2.42MVolume16.050Open16.000Pre Close39.99MTurnover2.41%Turnover RatioLossP/E (Static)101.85MShares34.87052wk High1.77P/B1.68BFloat Cap13.95052wk Low--Dividend TTM100.57MShs Float202.730Historical High--Div YieldTTM8.66%Amplitude9.180Historical Low16.536Avg Price1Lot Size
Intellia Therapeutics Key Stats
Intellia Therapeutics Q3 2024 Earnings Date
Currency：USDNov 7, 2024
| Estimate (YoY) |
Actual (YoY) |
Vs Estimate (% Chg) |
|
| Revenue |
7.86M
|
9.11M
|
+1.25M
|
| Beat Est. |
-34.49%
|
-24.02%
|
+15.97%
|
| EPS |
-1.39
|
-1.34
|
+0.05
|
| Beat Est. |
-0.38%
|
+2.90%
|
+3.26%
|
Analyst Rating
Nov 8, 2024
Intellia Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Intellia Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
